Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase
- PMID: 18587408
- PMCID: PMC2826895
- DOI: 10.1038/nm1784
Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase
Abstract
Recent efforts have revealed that numerous protein-coding messenger RNAs have natural antisense transcript partners, most of which seem to be noncoding RNAs. Here we identify a conserved noncoding antisense transcript for beta-secretase-1 (BACE1), a crucial enzyme in Alzheimer's disease pathophysiology. The BACE1-antisense transcript (BACE1-AS) regulates BACE1 mRNA and subsequently BACE1 protein expression in vitro and in vivo. Upon exposure to various cell stressors including amyloid-beta 1-42 (Abeta 1-42), expression of BACE1-AS becomes elevated, increasing BACE1 mRNA stability and generating additional Abeta 1-42 through a post-transcriptional feed-forward mechanism. BACE1-AS concentrations were elevated in subjects with Alzheimer's disease and in amyloid precursor protein transgenic mice. These data show that BACE1 mRNA expression is under the control of a regulatory noncoding RNA that may drive Alzheimer's disease-associated pathophysiology. In summary, we report that a long noncoding RNA is directly implicated in the increased abundance of Abeta 1-42 in Alzheimer's disease.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2826895/bin/nihms-175899-f0001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2826895/bin/nihms-175899-f0002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2826895/bin/nihms-175899-f0003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2826895/bin/nihms-175899-f0004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2826895/bin/nihms-175899-f0005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2826895/bin/nihms-175899-f0006.gif)
Comment in
-
Regulatory RNA goes awry in Alzheimer's disease.Nat Med. 2008 Jul;14(7):711-2. doi: 10.1038/nm0708-711. Nat Med. 2008. PMID: 18607365 No abstract available.
Similar articles
-
The β-Secretase Enzyme BACE1: A Biochemical Enigma for Alzheimer's Disease.CNS Neurol Disord Drug Targets. 2020;19(3):184-194. doi: 10.2174/1871527319666200526144141. CNS Neurol Disord Drug Targets. 2020. PMID: 32452328 Review.
-
Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1‑AS expression.Mol Med Rep. 2014 Sep;10(3):1275-81. doi: 10.3892/mmr.2014.2351. Epub 2014 Jun 23. Mol Med Rep. 2014. PMID: 24970022 Free PMC article.
-
Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.Eur J Neurosci. 2013 Jun;37(12):1962-9. doi: 10.1111/ejn.12235. Eur J Neurosci. 2013. PMID: 23773065
-
BACE1 in Alzheimer's disease.Clin Chim Acta. 2012 Dec 24;414:171-8. doi: 10.1016/j.cca.2012.08.013. Epub 2012 Aug 20. Clin Chim Acta. 2012. PMID: 22926063 Review.
-
Evidence for natural antisense transcript-mediated inhibition of microRNA function.Genome Biol. 2010;11(5):R56. doi: 10.1186/gb-2010-11-5-r56. Epub 2010 May 27. Genome Biol. 2010. PMID: 20507594 Free PMC article.
Cited by
-
LncRNAs, nuclear architecture and the immune response.Nucleus. 2024 Dec;15(1):2350182. doi: 10.1080/19491034.2024.2350182. Epub 2024 May 13. Nucleus. 2024. PMID: 38738760 Free PMC article. Review.
-
Epigenetic modifications of DNA and RNA in Alzheimer's disease.Front Mol Neurosci. 2024 Apr 25;17:1398026. doi: 10.3389/fnmol.2024.1398026. eCollection 2024. Front Mol Neurosci. 2024. PMID: 38726308 Free PMC article. Review.
-
Recent Updates on Epigenetic-Based Pharmacotherapy for Atherosclerosis.Diabetes Metab Syndr Obes. 2024 Apr 29;17:1867-1878. doi: 10.2147/DMSO.S463221. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38706808 Free PMC article. Review.
-
Natural antisense transcripts as versatile regulators of gene expression.Nat Rev Genet. 2024 Apr 17. doi: 10.1038/s41576-024-00723-z. Online ahead of print. Nat Rev Genet. 2024. PMID: 38632496 Review.
-
RNA and neuronal function: the importance of post-transcriptional regulation.Oxf Open Neurosci. 2022 Jul 7;1:kvac011. doi: 10.1093/oons/kvac011. eCollection 2022. Oxf Open Neurosci. 2022. PMID: 38596700 Free PMC article. Review.
References
-
- Goedert M, Spillantini MG. A century of Alzheimer’s disease. Science. 2006;314:777–781. - PubMed
-
- Faghihi MA, Mottagui-Tabar S, Wahlestedt C. Genetics of neurological disorders. Expert Rev. Mol. Diagn. 2004;4:317–332. - PubMed
-
- Monaco S, Zanusso G, Mazzucco S, Rizzuto N. Cerebral amyloidoses: molecular pathways and therapeutic challenges. Curr. Med. Chem. 2006;13:1903–1913. - PubMed
-
- Esposito G, et al. CB1 receptor selective activation inhibits β-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons. Neurosci. Lett. 2006;404:342–346. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials